Contact Lenses News and Research

RSS

Contact lenses are explicitly designed optical devices that can be worn directly on the cornea of the eye. People with poor eyesight wear contact lenses, which helps to refocus oncoming light rays on the retina to achieve a clear vision. Contact lenses increase or decrease the focusing potential of the cornea, and thereby directly project light onto the retina and aid in treating refractive errors.

Spring is busting out all over - and so are eye allergies

Ah, spring. The time of year when trees and flowers bloom sending pollen into the air and causing sneezing, runny noses and watery eyes. The Asthma & Allergy Foundation of America estimates that 1 in 5 individuals are affected by eye allergies.

15 Apr 2010

Tβ4 therapy for ocular disorders closer to reality

RegeneRx Biopharmaceuticals, Inc. announced today that Tβ4, a synthetic version of a naturally occurring peptide that is the basis for the company's product candidates, will be the subject of three poster presentations at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to be held in Fort Lauderdale, Florida from May 2-6, 2010.

9 Apr 2010

ReVision Optics initiates US clinical trial of PresbyLens corneal inlay

ReVision Optics, a leading company in the research, development and manufacture of custom optical products to correct and maintain vision, announced today that it has begun its US clinical trial of the PresbyLens® corneal inlay. The clinical trial will evaluate the PresbyLens® corneal inlay for the correction of presbyopia, the age-related loss of near vision. The study began on April 6th with the treatment of three subjects by clinical investigator Dr. Stephen Slade of the Slade & Baker Vision Center in Houston, Texas.

9 Apr 2010

New strategies to help allergy sufferers survive the winds of spring, summer

Every spring and summer, millions of Americans dread the trip to the park, the playground, or participating in any of the myriad activities that trigger outdoor allergy symptoms.

8 Apr 2010

HOLCOMB C3-R cures bobsledder of impending blindness, helps win gold at 2010 Winter Olympics

It was an amazing triumph of the will, when the U.S. Bobsled Team, led by captain Steve Holcomb, took home the first Gold in 62 years at the 2010 Winter Olympics in Vancouver. An amazing feat, yet only the tip of the iceberg, for 2 years prior Holcomb underwent a brand new procedure to cure his impending blindness.

7 Apr 2010

Common remedies can make ocular symptoms worse: MOA

The Minnesota Optometric Association offers advice for the thousands around the state who suffer from the itchy, watery eye symptoms associated with seasonal Spring allergens. The culprits exist indoors and out: pollen, mold, dust mites and pet dander.

1 Apr 2010

Vision CRC scientists discover new technology to control myopia

Scientists from the Vision Cooperative Research Centre in Australia today announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners - the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.

31 Mar 2010

NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

NovaBay Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported full-year and fourth quarter financial results for 2009. The company also highlighted recent progress of its proprietary and partnered development programs.

30 Mar 2010

SENSIMED Triggerfish developed to diagnose and treat patients with glaucoma

STMicroelectronics, the world's leading supplier of MEMS (Micro-Electro-Mechanical Systems) devices for consumer and portable applications, has announced that it will develop and supply a wireless MEMS sensor that acts as a transducer, antenna and mechanical support for additional read-out electronics in a breakthrough platform developed by Swiss company Sensimed AG.

26 Mar 2010

Industry continues to give thumbs up to overhaul

On Tuesday, "[p]rovider groups hailed the president's historic signing of the Senate's healthcare reform bill, which seeks to overhaul the healthcare system through the establishment of a new insurance marketplace, expansions to Medicaid and various insurance reforms," Modern Healthcare reports.

25 Mar 2010

Special medicated contact lenses can help treat common eye disorders

The popular dietary supplement vitamin E, loaded into special medicated contact lenses, can keep glaucoma medicine near the eye - where it can treat that common disease- almost 100 times longer than possible with current commercial lenses, scientists reported here today.

25 Mar 2010

Maxine Morgan Eyewear unveils comprehensive line of specialized lenses, frames and specialty products

Maxine Morgan Eyewear unveils its comprehensive line of specialized lenses, frames and specialty products with a major presence here at the International Vision Expo East, booth # MS1060, medical science pavilion, in the Jacob K. Javits Convention Center.

19 Mar 2010

Bausch + Lomb ReNu MultiPlus multi-purpose solution named "Best Eye Care Product of the Year - Asia"

Bausch + Lomb ReNu MultiPlus(R) multi-purpose solution has been named "Best Eye Care Product of the Year - Asia" for its revolutionary bottle design at this year's A.S. Watson Global Suppliers Awards. Held in Hong Kong on 4 March 2010, the awards recognize international brands for outstanding performance in bringing innovation, differentiation and excitement to the consumer experience.

19 Mar 2010

Menicon acquires all shares of Tomey from Tomey Shoji

Menicon Co., Ltd. announced on March 17 that it had acquired all shares of Tomey Co., Ltd. from Tomey Shoji Inc. The deal was completed on February 1, 2010.

19 Mar 2010

Babies born with severe cleft palates: Promising breakthrough without complex surgery

Scientists working on a treatment for babies born with cleft palates have made a promising breakthrough and the first clinical trials are planned for early next year. Clefts are the most common birth defect in Britain, with one in every 700 babies affected; currently in severe cases radical surgery is required to correct the problem, and in addition future complications can occur as the child grows into an adult.

18 Mar 2010

Healthy communication between patients and physicians reduces medical errors

National Patient Safety Awareness Week is taking place from March 7th to the 13th. This year’s theme is all about healthy communication between patients and their physicians. The simple theme Let’s Talk: Healthy Conversations for Safer Healthcare is aimed at helping people become more involved in their own health care.

6 Mar 2010

Unilens Vision's royalty income for FY2010 second-quarter increases 12.7%

Unilens Vision Inc., which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the second quarter ended December 31, 2009 (FY2010).

26 Feb 2010

Visionworks launches optical retail center in Cranberry Commons Mall

Today Cranberry residents will see the grand opening of the first Visionworks® location in western PA. Visionworks is a full-service optical retail center that features several thousand private label and designer frames along with contact lenses at value prices.

6 Feb 2010

Renowned ophthalmologist performs innovative procedure on patient suffering from severe visual impairment

Ten years ago, Southern Californian resident Kenny Atkins suffered from severe visual impairment caused by coning of the cornea, otherwise known as keratoconus. Prescription glasses and contact lenses proved to be ineffective, and Atkins needed a solution fast – as an ocean lifeguard, Atkins’ ability to see could mean the difference between life and death.

6 Jan 2010

Enrollment for sham-controlled study of radiation therapy for treatment of wet AMD announced

Oraya Therapeutics, Inc., announced today that enrollment is now underway for the first ever masked and sham-controlled study to demonstrate the efficacy and safety of radiation therapy for the treatment of wet age-related macular degeneration (AMD).

6 Jan 2010